Results
|
|
1981.
|
|
|
|
1982.
|
|
|
|
1983.
|
Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trial. [electronic resource] by
- Ory, Daniel S
- Ottinger, Elizabeth A
- Farhat, Nicole Yanjanin
- King, Kelly A
- Jiang, Xuntian
- Weissfeld, Lisa
- Berry-Kravis, Elizabeth
- Davidson, Cristin D
- Bianconi, Simona
- Keener, Lee Ann
- Rao, Ravichandran
- Soldatos, Ariane
- Sidhu, Rohini
- Walters, Kimberly A
- Xu, Xin
- Thurm, Audrey
- Solomon, Beth
- Pavan, William J
- Machielse, Bernardus N
- Kao, Mark
- Silber, Steven A
- McKew, John C
- Brewer, Carmen C
- Vite, Charles H
- Walkley, Steven U
- Austin, Christopher P
- Porter, Forbes D
Producer: 20180927
In:
Lancet (London, England) vol. 390
Availability: No items available.
|
|
|
1984.
|
|
|
|
1985.
|
|
|
|
1986.
|
|
|
|
1987.
|
|
|
|
1988.
|
|
|
|
1989.
|
|
|
|
1990.
|
|
|
|
1991.
|
|
|
|
1992.
|
|
|
|
1993.
|
|
|
|
1994.
|
|
|
|
1995.
|
|
|
|
1996.
|
|
|
|
1997.
|
|
|
|
1998.
|
|
|
|
1999.
|
|
|
|
2000.
|
|